SL
ANIK icon

Savior LLC’s Anika Therapeutics ANIK Stock Holding History

Savior LLC’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-60
Closed -$3K – 216
2021
Q2 		$3K Hold
60
– – ﹤0.01% 655
2021
Q1 		$2K Hold
60
– – ﹤0.01% 726
2020
Q4 		$3K Hold
60
– – ﹤0.01% 643
2020
Q3 		$2K Hold
60
– – ﹤0.01% 659
2020
Q2 		$2K Hold
60
– – ﹤0.01% 619
2020
Q1 		$2K Hold
60
– – ﹤0.01% 602
2019
Q4 		$3K Buy
+60
New +$3.48K ﹤0.01% 664

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Savior LLC's ANIK Position: Q3 2021 in Review

Savior LLC sold out of Anika Therapeutics (ANIK) in Q3 2021, closing a stake of 60 shares — an estimated $3K sold.

Savior LLC first reported a position in ANIK in Q4 2019 and held it in 7 quarters. The position peaked at $3K in Q2 2021. 131 funds tracked by Wall St. Rank hold ANIK as of Q3 2021.

  • Savior LLC reported no remaining Anika Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Savior LLC sold 60 Anika Therapeutics shares in Q3 2021, an estimated $3K.
  • Savior LLC first reported a position in Anika Therapeutics in Q4 2019 and held it in 7 quarters.
  • Savior LLC's Anika Therapeutics position peaked at $3K in Q2 2021.
  • 131 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.